Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 11NIH 4NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Leukemia 52Leukemia, Myeloid, Acute 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Lymphoma 23Burkitt Lymphoma 16Leukemia, Monocytic, Acute 15Leukemia, Myelomonocytic, Acute 14Leukemia, Megakaryoblastic, Acute 14Leukemia, Erythroblastic, Acute 14Congenital Abnormalities 12Leukemia, Biphenotypic, Acute 9Myelodysplastic Syndromes 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Leukemia, Eosinophilic, Acute 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Follicular 3Leukemia, Basophilic, Acute 3Anemia, Refractory, with Excess of Blasts 3Waldenstrom Macroglobulinemia 2Recurrence 2Neutropenia 2Myeloproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Vincristine 6Radiotherapy 5Prednisone 5Doxorubicin 5Cyclophosphamide 5Gemcitabine 4Cisplatin 4Rituximab 3Methotrexate 3Cytarabine 3Crizotinib 3ibritumomab tiuxetan 2Vinorelbine 2Methylprednisolone 2Etoposide 2Drug Therapy 2Dexamethasone 2merphos 1liposomal amphotericin B 1ixabepilone 1imetelstat 1Whole-Body Irradiation 1Watchful Waiting 1Vinblastine 1VAP-cyclo protocol 1Topotecan 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Razoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Large-Cell, Anaplastic × Cytarabine × Clear all
NCT00078949 2023-08-23

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Canadian Cancer Trials Group

Phase 3 Completed
849 enrolled 13 charts
Lymphoid

Burkitt Lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic

NCT00003388 2023-06-22

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Completed
38 enrolled
Lymphoid

Lymphoma, Lymphoma, Large-Cell, Anaplastic

NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡